Time to surgery following neoadjuvant chemotherapy for breast cancer impacts residual cancer burden, recurrence, and survival

Sutton Thomas L.; Schlitt Alexander; Gardiner Stuart K.; Johnson Nathalie; Garreau Jennifer R.

首页> 外文期刊>Journal of Surgical Oncology >Time to surgery following neoadjuvant chemotherapy for breast cancer impacts residual cancer burden, recurrence, and survival

【24h】

Time to surgery following neoadjuvant chemotherapy for breast cancer impacts residual cancer burden, recurrence, and survival

机译：在Neoadjuvant化疗进行乳腺癌后的手术时间会影响残留的癌症负担，再次发生和生存

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background The impact of length of time to surgery (TTS) on oncologic outcomes following neoadjuvant chemotherapy (NAC) in breast cancer patients is unclear. We investigated the relationship between TTS on residual cancer burden (RCB) score and oncologic outcomes.

机译：背景：乳腺癌患者新辅助化疗（NAC）后，手术时间（TTS）对肿瘤预后的影响尚不清楚。我们调查了TTS对残余癌症负担（RCB）评分与肿瘤预后之间的关系。

著录项

来源
《Journal of Surgical Oncology 》 |2020年第8期| 共9页
作者
Sutton Thomas L.; Schlitt Alexander; Gardiner Stuart K.; Johnson Nathalie; Garreau Jennifer R.;
展开▼
作者单位

Oregon Hlth &

Sci Univ Dept Surg Portland OR 97201 USA;

Western Univ Hlth Sci Coll Osteopath Med Pacific Northwest Lebanon OR USA;

Legacy Hlth Devers Eye Inst Legacy Res Inst Portland OR USA;

Legacy Canc Inst Legacy Med Grp Surg Oncol 1040 NW 22nd Ave Suite 560 Portland OR 97227 USA;

Legacy Canc Inst Legacy Med Grp Surg Oncol 1040 NW 22nd Ave Suite 560 Portland OR 97227 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学 ;
关键词
breast cancer; neoadjuvant chemotherapy; oncologic outcomes; time to surgery;

机译：乳腺癌;新辅助化疗;肿瘤学结果;手术时间到了;

相似文献

外文文献
中文文献
专利

1. Can trastuzumab emtansine be replaced by additional chemotherapy plus targeted therapy for HER2-overexpressing breast cancer patients with residual disease after neoadjuvant chemotherapy? [J] . Juan Wu, Rong Kong, Shen Tian, 中国癌症研究（英文版） . 2019 ,第006期
2. Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy [J] . Yu-Ge Bai, Guo-Xuan Gao, Hong Zhang, 中华医学杂志（英文版） . 2020 ,第005期
3. Decrease in the Ki67 index during neoadjuvant chemotherapy predicts favorable relapse-free survival in patients with locally advanced breast cancer [J] . Chunfa Chen, Yuling Zhang, Ziyi Huang, 癌症生物学与医学：英文版 . 2019 ,第003期
4. Decrease in the Ki67 index during neoadjuvant chemotherapy predicts favorable relapse-free survival in patients with locally advanced breast cancer [J] . Chunfa Chen, Yuling Zhang, Ziyi Huang, 癌症生物学与医学（英文版） . 2019 ,第003期
5. Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden [J] . Yuka Asano, Shinichiro Kashiwagi, Wataru Goto, BMC Cancer . 2017 ,第1期

机译：通过评估肿瘤浸润淋巴细胞和残留癌症负担来预测乳腺癌新辅助化疗后的生存率
6. Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden [J] . Yuka Asano, Shinichiro Kashiwagi, Wataru Goto, BMC Cancer . 2017 ,第1期

机译：通过评估肿瘤浸润淋巴细胞和残留癌症负担来预测乳腺癌新辅助化疗后的生存率
7. Clinical Outcomes Among Major Breast Cancer Subtypes After Neoadjuvant Chemotherapy: Impact on Breast Cancer Recurrence and Survival [J] . PAOLO ORSARIA Anticancer Research: International Journal of Cancer Research and Treatment . 2021 ,第5期

机译：Neoadjuvant化疗后主要乳腺癌亚型的临床结果：对乳腺癌复发和生存的影响
8. Deep learning predicts breast cancer recurrence in analysis of consecutive MRIs acquired during the course of neoadjuvant chemotherapy [C] . Karen Drukker, Alexandra Edwards, John Papaioannou, Medical Imaging Conference . 2020

机译：深度学习通过在新辅助化疗过程中获得的连续MRI分析来预测乳腺癌的复发
9. Coregistration of serial breast MR studies for augmenting neoadjuvant chemotherapy response evaluation in breast cancer patients. [D] . Chittineni, Ruparani. 2008

机译：增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
10. Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: A random forest survival approach [O] . Enora Laas, Anne-Sophie Hamy, Anne-Sophie Michel, 2012

机译：时间对局部复发的影响对接受新辅助化疗的乳腺癌患者转移发生的影响：随机森林生存方法
11. Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity [O] . Christoph Suppan, Florian Posch, Hannah Deborah Mueller, 2021

机译：早期乳腺癌后乳腺癌疗法复发模式，根据残留的癌症负担指数和降低新辅助治疗强度
12. Investigation of Antioxidant Supplements and Medicinal Herbs in Breast Cancer Recurrence and Survival. [R] . Fleischauer, A. T., Arab, L. 2002

机译：添加到阅览室添加到阅览室阅读软件下载阅读软件下载与<<乳腺癌复发和生存中抗氧化剂和中草药的研究>>

Time to surgery following neoadjuvant chemotherapy for breast cancer impacts residual cancer burden, recurrence, and survival

摘要

著录项

相似文献

相关主题

期刊订阅